Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

PROGYNY ($PGNY) Releases Q1 2026 Earnings, Stock Rises

None

PROGYNY ($PGNY) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of $0.50 per share, beating estimates of $0.30 by $0.20. The company also reported revenue of $328,500,000, missing estimates of $333,102,644 by $-4,602,644.

Stock price change since market close: +9.7%

You can see Quiver Quantitative's $PGNY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

PROGYNY Insider Trading Activity

PGNY Insider Trades

PROGYNY insiders have traded $PGNY stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:

  • PETER ANEVSKI (CHIEF EXECUTIVE OFFICER) purchased 79,500 shares for an estimated $1,930,896
  • MARK S. LIVINGSTON (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 21,975 shares for an estimated $560,362.
  • ALLISON SWARTZ (EVP, GC) has made 0 purchases and 6 sales selling 10,383 shares for an estimated $206,979.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

PROGYNY Hedge Fund Activity

We have seen 147 institutional investors add shares of PROGYNY stock to their portfolio, and 172 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

PROGYNY Analyst Ratings

Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citizens issued a "Market Outperform" rating on 01/20/2026

To track analyst ratings and price targets for PROGYNY, check out Quiver Quantitative's $PGNY forecast page.

PROGYNY Price Targets

Multiple analysts have issued price targets for $PGNY recently. We have seen 7 analysts offer price targets for $PGNY in the last 6 months, with a median target of $28.0.

Here are some recent targets:

  • Glen Santangelo from Barclays set a target price of $23.0 on 03/20/2026
  • Richard Close from Canaccord Genuity set a target price of $19.0 on 03/11/2026
  • David Larsen from BTIG set a target price of $30.0 on 03/05/2026
  • Jailendra Singh from Truist Securities set a target price of $28.0 on 03/02/2026
  • Scott Schoenhaus from Keybanc set a target price of $28.0 on 03/02/2026
  • Constantine Davides from Citizens set a target price of $30.0 on 01/20/2026
  • Lisa Gill from JP Morgan set a target price of $26.0 on 11/11/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles